We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+5.72%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$20.5B
AUM Growth
+$1.25B
(+6.5%)
Cap. Flow
+$361M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
1,000
New
89
Increased
345
Reduced
485
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$309M |
| 2 |
Stellantis
STLA
|
+$198M |
| 3 |
Mastercard
MA
|
+$54.7M |
| 4 |
Truist Financial
TFC
|
+$47.4M |
| 5 |
Walt Disney
DIS
|
+$41.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$55.7M |
| 2 |
Skyworks Solutions
SWKS
|
+$47.7M |
| 3 |
RTX Corp
RTX
|
+$38.8M |
| 4 |
Adobe
ADBE
|
+$35.9M |
| 5 |
Intercontinental Exchange
ICE
|
+$32.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.63% |
| 2 | Financials | 14.68% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Healthcare | 12.77% |
| 5 | Communication Services | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAVN
726
DELISTED
Raven Industries Inc
RAVN
| $1.43M | 0.01% |
37,422
-20,167
| -35% | -$753K |
|
|
SYNH
727
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.43M | 0.01% |
+18,875
| New | +$1.42M |
|
728
A.O. Smith
AOS
$8.55B
| $1.42M | 0.01% |
21,033
-6,173
| -23% | -$375K |
|
|
SWAV
729
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.42M | 0.01% |
10,918
-7,009
| -39% | -$841K |
|
730
Li Auto
LI
$14.4B
| $1.42M | 0.01% |
+56,813
| New | +$1.64M |
|
731
Cable One
CABO
$237M
| $1.41M | 0.01% |
770
-1,277
| -62% | -$2.5M |
|
732
Lennox International
LII
$15B
| $1.4M | 0.01% |
4,488
-24,010
| -84% | -$6.95M |
|
733
Applied Industrial Technologies
AIT
$12.4B
| $1.39M | 0.01% |
15,189
| – | – |
|
734
Blackstone Mortgage Trust
BXMT
$2.77B
| $1.39M | 0.01% |
+44,665
| New | +$1.3M |
|
735
10x Genomics
TXG
$5.88B
| $1.37M | 0.01% |
7,562
-4,362
| -37% | -$753K |
|
736
Boston Beer
SAM
$1.95B
| $1.37M | 0.01% |
1,133
-247
| -18% | -$259K |
|
737
Kura Oncology
KURA
$793M
| $1.36M | 0.01% |
48,073
+4,881
| +11% | +$154K |
|
738
Cognex
CGNX
$9.62B
| $1.36M | 0.01% |
16,363
-5,622
| -26% | -$468K |
|
739
Nomad Foods
NOMD
$1.77B
| $1.36M | 0.01% |
49,449
-20,609
| -29% | -$533K |
|
740
Neurocrine Biosciences
NBIX
$18.2B
| $1.36M | 0.01% |
13,950
+750
| +6% | +$78.6K |
|
741
Guardant Health
GH
$19.1B
| $1.35M | 0.01% |
8,848
-2,849
| -24% | -$431K |
|
|
SWTX
742
DELISTED
SpringWorks Therapeutics
SWTX
| $1.34M | 0.01% |
+18,279
| New | +$1.43M |
|
743
Aecom
ACM
$9.46B
| $1.33M | 0.01% |
+20,769
| New | +$1.18M |
|
744
Veracyte
VCYT
$4.45B
| $1.33M | 0.01% |
24,736
-15,159
| -38% | -$873K |
|
745
Krystal Biotech
KRYS
$10.7B
| $1.32M | 0.01% |
17,198
-11,896
| -41% | -$865K |
|
746
Castle Biosciences
CSTL
$742M
| $1.32M | 0.01% |
+19,319
| New | +$1.45M |
|
747
STAAR Surgical
STAA
$1.19B
| $1.32M | 0.01% |
12,545
-10,210
| -45% | -$1.02M |
|
748
Viking Therapeutics
VKTX
$3.88B
| $1.31M | 0.01% |
207,322
+18,496
| +10% | +$130K |
|
749
Freshpet
FRPT
$3.04B
| $1.31M | 0.01% |
8,241
-3,531
| -30% | -$533K |
|
750
Cirrus Logic
CRUS
$6.76B
| $1.31M | 0.01% |
+15,407
| New | +$1.33M |
|
Similar funds
QCM
NAMI
Aviva's Q1 2021 Portfolio in Review
As of Q1 2021, Aviva held 1,000 positions worth $20.5B, up 6.5% from $19.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Aviva's Q1 2021 filing shows 89 new, 345 increased, 485 reduced and 62 closed positions. Its largest new stake was Ferguson: 2,534,285 shares worth $302M. The largest sale was Apple, an estimated $55.7M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- Aviva's largest Q1 2021 buy was Ferguson: 2,534,285 shares worth $302M.
- Aviva added most to Stellantis in Q1 2021, an estimated $198M increase.
- Aviva's biggest Q1 2021 reduction was Apple, cutting an estimated $55.7M.
- Aviva fully exited Tiffany & Co. in Q1 2021, selling an estimated $7.08M.
- Aviva's ten largest holdings make up 23% of its $20.5B portfolio in Q1 2021.
- Aviva opened 89 new positions and closed 62 in Q1 2021.
- Aviva's portfolio value rose 6.5% quarter-over-quarter to $20.5B.
Based on Aviva's 13F filing for Q1 2021, filed 13 May 2021.